Aug 02, 2021 / 09:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the second quarter 2021 financial results and corporate update conference call. (Operator Instructions) I would now like to hand the conference over to your first speaker today, Joshua Higa, Director of Investor Relations. Thank you. Please go ahead.
Joshua Higa - Ultragenyx Pharmaceutical Inc. - Director of IR & Corporate Communications
Good afternoon, and welcome to the Ultragenyx financial results and corporate update conference Call for the second quarter 2021. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com. I am Joshua Higa, Director of Investor Relations. Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Camille Bedrosian, Chief Medical Officer; and Erik Harris, Chief Commercial Officer. Mardi Dier, our Chief Financial Officer, had an unavoidable flight delay and is not able to join us on today's call.
I would like to remind investors that this call will include forward-looking statements within
Q2 2021 Ultragenyx Pharmaceutical Inc Earnings Call Transcript
Aug 03, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers